Important adverse events to be evaluated in antidepressant trials and meta-analyses in depression: a large international preference study including patients and healthcare professionals

Conclusions These most important NSAEs should be systematically reported in antidepressant trials. Clinical implications The most important NSAEs should contribute to the core outcome set for harms in depression.

http://ebmh.bmj.com/cgi/content/short/25/e1/e41?rss=1

Source: Evidence-Based Mental Health - December 19, 2022 Category: Psychiatry & Psychology Authors: Chevance, A., Tomlinson, A., Ravaud, P., Touboul, S., Henshall, C., Tran, V.-T., Cipriani, A. Tags: Open access Pharmacological treatments Source Type: research